Synonyms: Kepivance® | keratinocyte growth factor
palifermin is an approved drug (FDA (2004), EMA (2005))
Compound class:
Peptide
Comment: Palfermin is a modified truncated form of human keratinocyte growth factor produced by recombinant DNA technology.
|
Classification ![]() |
|
Compound class | Peptide |
Approved drug? | Yes (FDA (2004), EMA (2005)) |
Approved drug? | Yes. FDA (2004) | EMA (2005) |
International Nonproprietary Names ![]() |
|
INN number | INN |
8186 | palifermin |
Synonyms ![]() |
Kepivance® | keratinocyte growth factor |
Database Links ![]() |
|
CAS Registry No. | 162394-19-6 (source: Scifinder) |
ChEMBL Ligand | CHEMBL1201821 |
DrugBank Ligand | DB00039 |
GtoPdb PubChem SID | 178103536 |
PubChem SID | 135252604 |
Search PubMed clinical trials | palifermin |
Search PubMed titles | palifermin |
Search PubMed titles/abstracts | palifermin |
Wikipedia | Palifermin |